Acquisition Strengthens Constella's U.S. Presence
DURHAM, N.C., October 19, 2006-Constella Group, a global provider of professional health services, announced that it has signed a definitive agreement to acquire Lineberry Research Associates (LRA), a full-service, U.S. contract research organization and consulting firm based in Research Triangle Park, N.C.
LRA employs more than 75 people, all of whom will join Constella's pharmaceutical product development business unit once the acquisition is complete, which is expected to occur within the next 30 days.
LRA will begin operating under the Constella Group name in the next few months.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
FDA Issues Complete Response Letter to Replimune for RP1 Combination Therapy in Advanced Melanoma
July 22nd 2025The FDA’s complete response letter cited concerns that the Phase I/II IGNYTE (NCT03767348) trial in advanced melanoma was not an adequate, well-controlled study and that its heterogeneous patient population limited interpretability, preventing approval in its current form.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.